May 19, 2010 — A voluntary recall has been issued for all lots of Baxter's hyaluronidase human injection (Hylenex) because of the presence of particulate matter, identified as glass, according to a ...

Dec. 8, 2005 — The US Food and Drug Administration (FDA) has approved bivalirudin injection for use in patients with or at risk of heparin-induced thrombocytopenia and thrombosis syndrome undergoing ...

DEERFIELD, Ill., May 17, 2010 (BUSINESS WIRE) -- Baxter International Inc. announced today that a voluntary recall of all manufactured lots of HYLENEX recombinant (hyaluronidase human injection) has ...

Baxter International Inc. (NYSE: BAX) today announced the commercial launch of HYLENEX recombinant (hyaluronidase human injection) for use in pediatric rehydration at the 2009 American College of ...

Baxter announced a voluntary recall of all lots of Hylenex recombinant (hyaluronidase human injection) as a precautionary measure due to instances of particulate matter observed in a limited number of ...

The FDA has approved Halozyme Therapeutics' Hylenex recombinant (hyaluronidase human injection) for use as an adjuvant agent to increase the absorption and dispersion of other injected drugs. "We are ...

Halozyme Therapeutics has identified a corrective action plan to get its Hylenex pediatric-rehydration product back on the market. It completed a manufacturing root cause investigation and is prepping ...

Blac Chyna underwent a sixth procedure to dissolve her facial fillers after they “migrated down” her face. On Monday, the former OnlyFans model documented herself getting another round of Hylenex ...

TEL AVIV (MarketWatch) -- The U.S. Food and Drug Administration cleared Halozyme Therapeutics Inc.'s Hylenex recombinant for use as an adjuvant agent to increase the absorption and dispersion of ...

Agreement includes $10 million upfront and a $20-million equity investment. Halozyme Therapeutics and Baxter Healthcare expanded their existing Hylenex recombinant (hyaluronidase human injection) ...